loading page

Thoracic surgical diseases and complications related to tobacco use
  • Mehmet Degirmenci,
  • CELAL KUŞ
Mehmet Degirmenci
Kahramanmaras Sutcu Imam Universitesi
Author Profile
CELAL KUŞ
Author Profile

Peer review status:UNDER REVIEW

29 Jul 2020Submitted to International Journal of Clinical Practice
31 Jul 2020Assigned to Editor
31 Jul 2020Submission Checks Completed
02 Aug 2020Reviewer(s) Assigned

Abstract

Objective: We aimed to investigate the effects of tobacco in the diseases that may require surgical treatment and thus contribute to the prevention of the development and treatment of lung diseases Background: Tobacco can make respiratory diseases more complicated by affecting their respiratory functions in a short or long time and can increase mortality and morbidity related to these diseases. Method: We retrospectively analyzed 754 patients aged 18 - 95. Patients included in the study were divided into two groups as tobacco users and non-users. We examined patients in each group in terms of age, gender, diagnosis of the disease, complications developing during and after treatment, and length of hospital stay. Results: The patients consisted of 536 (71.1%) males and 218 (28.9%) females. The average age of patients was 46.91 ± 22.07 (Min: 18 Max: 95). 56.1% of all patients and 73.3% of male patients used tobacco, and tobacco use was more common among men (X2 = 223.216, p < 0.001). Tobacco use was significantly higher in patients under 35 years of age (X2 = 45.342, p < 0.001). The average length of hospital stay was 9.41 ± 7.26 days for tobacco users and 8.15 ± 6.47 days for non-tobacco users (Mann-Whitney U test = 61949.0, p<0.007). Complications occurred in 96 of 754 patients, included in the study 76 (79.2%) of whom used tobacco, and 20 (20.8%) did not use tobacco (X2 = 23.765, p<0.001). Spontaneous pneumothorax and lung cancer have been observed significantly more in tobacco users (respectively X2 = 96.196, p < 0.001; X2 = 4.735, p = 0.030). Conclusion: We recommend supporting tobacco control programs to prevent the effect of tobacco use on pulmonary surgical diseases, and the development of pulmonary complications. Keywords: tobacco use, postoperative pulmonary complication, thoracic surgery, smoking, surgical diseases